Literature DB >> 10182099

Current concepts in the management of central retinal vein occlusion.

M J Cooney1, S Fekrat, D Finkelstein.   

Abstract

The results of the Central Vein Occlusion Study guide the management of complications of macular edema and neovascularization. Panretinal photocoagulation was shown to be beneficial for eyes with at least 2 hours of iris neovascularization or any angle neovascularization. Grid-pattern laser photocoagulation for perfused macular edema did not show a significant beneficial effect. Recently, several reports have suggested restoring venous outflow by 1) creating a chorioretinal anastomosis, 2) administering recombinant tissue plasminogen activator, 3) cannulating the retinal vein transvitreally, or 4) transecting the posterior scleral ring.

Entities:  

Mesh:

Year:  1998        PMID: 10182099     DOI: 10.1097/00055735-199806000-00008

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion.

Authors:  Sengül C Ozdek; Bahri Aydin; Gökhan Gürelik; Umut Bahçeci; Berati Hasanreisoğlu
Journal:  Int Ophthalmol       Date:  2006-06-16       Impact factor: 2.031

2.  Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series.

Authors:  Susanne Binder; Tina Aggermann; Simon Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-04       Impact factor: 3.117

3.  A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group.

Authors:  Tina Aggermann; Simon Brunner; Ilse Krebs; Paulina Haas; Irene Womastek; Werner Brannath; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-08       Impact factor: 3.117

4.  Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.

Authors:  Tianwei Qian; Mengya Zhao; Yongjing Wan; MengXiao Li; Xun Xu
Journal:  BMJ Open       Date:  2018-12-28       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.